Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1KO3P
|
|||
| Drug Name |
SXC-2023
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Trichotillomania [ICD-11: 6B25.0] | Phase 2 | [1] | |
| Company |
Promentis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cystine/glutamate transporter (SLC7A11) | Target Info | Activator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03797521) A Study in Patients With Trichotillomania (TTM). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Promentis Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.